ARCHIVES

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

NCI Lists Projected Grant Paylines

February 16, 1996

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999